Skip to main content

Advertisement

Table 3 Clinical features of participants in the gout analysis

From: Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout

  Percentage with data All (n = 2,578) Controls (1,368) Cases (1,210) P
Age, years 100 52.1 (16.4) 47.0 (16.5) 57.8 (14.4) 4.9 × 10−66*
Male sex, n (%) 100 1739 (67.5) 740 (54.1) 999 (82.6) <1.0 × 10−5**
NZ East Polynesian dataset, n (%) 100 901 (35.0) 583 (42.6) 319 (26.4) <1.0 × 10−5**
NZ West Polynesian dataset, n (%) 100 597 (23.2) 271 (19.8) 326 (26.9)
NZ Mixed East/West Polynesian dataset, n (%) 100 92 (3.6) 64 (4.7) 28 (2.3)
NZ Caucasian dataset, n (%) 100 987 (38.3) 450 (32.9) 537 (44.4)
Serum urate at the time of recruitment, mmol/L 86.5 0.39 (0.11) 0.37 (0.10) 0.43 (0.11) 5.9 × 10−37*
Triglycerides, mmol/L 86.9 2.14 (1.4) 1.93 (1.18) 2.39 (1.60) 2.3 × 10−14*
Body mass index, kg/m2 100 32.4 (7.6) 31.3 (7.5) 33.6 (7.6) 2.6 × 10−15*
Fruit intake, pieces/day 98.9 2.9 (4.6) 2.8 (4.2) 3.0 (5.0) 0.27*
Kidney disease, n (%) 98.0 295 (11.7) 57 (4.3) 238 (20.1) <1.0 × 10−5**
Hypertension, n (%) 98.3 975 (38.5) 309 (23.0) 666 (55.9) <1.0 × 10−5**
  1. Unless specified, data are presented as mean (SD)
  2. NZ New Zealand
  3. *Two-sample t test with unequal variances
  4. **Chi-square test